04-30-2015, 03:21 PM
GILD crushed earnings
Gilead Sciences (NASDAQ:GILD): Q1 EPS of $2.94 beats by $0.62.
Revenue of $7.6B (+52.0% Y/Y) beats by $680M.
Gilead Sciences (NASDAQ:GILD): Q1 EPS of $2.94 beats by $0.62.
Revenue of $7.6B (+52.0% Y/Y) beats by $680M.